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CTs. On the other hand, RCTs will soon establish whether
re-EP is an effective means of HIV prevention. If Pre-EP
s proven effective, there will be substantial challenges in
ormulating a policy framework to guide its use.
oi:10.1016/j.ijid.2008.05.153
2.004
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Brown University, Providence, RI, USA
he possibility that antiretroviral drugs may be useful for
IV prevention has been suggested by animal studies that
ave documented that if these medications are used before
r after a retroviral challenge, they can protect against
he development of HIV infection. Epidemiological stud-
es in HIV discordant couples suggest that individuals with
ower plasma RNA levels are less likely to transmit HIV to
heir sexual partners. These ﬁndings have lent support to
ew HIV prevention approaches that include the evalua-
ion of the use of pre- and post-exposure prophylaxis (PrEP
nd PEP) in high risk HIV-uninfected persons, and studies
f the use of antiretroviral drugs to lower plasma RNA in
eople who are in discordant couples, in order to decrease
he likelihood of HIV transmission. Questions that remain
o be addressed include whether the beneﬁts of decreas-
ng HIV transmission are offset by behavioral disinhbition,
rug toxicities, and costs. An additional set of important
onsiderations include the timing and duration of antiretro-
iral drug use and whether these compounds are best used
s topical microbicides applied to the cervicovagingal or
ectal mucosa, or whether oral chemoprophylaxis is more
ffective. Over the next few years, several thousand at risk
ersons will be evaluated in efﬁcacy trials to address the
ptimal uses of antiretroviral medications for HIV preven-
ion.
oi:10.1016/j.ijid.2008.05.154
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ick-borne rickettsial diseases are usually called spotted
evers. Their agents, rickettsiae from spotted fever group
SFG), are obligate intracellular bacteria widespread in
ature and associated with parasitic blood-feeding arthro-
ods. Ixodid ticks are common human parasites and they
ay host different microbial pathogens that are often
ransmitted via ticks feeding on humans. Humans are not
atural hosts in rickettsial lifecycle, but due to high fre-
uency of tick bites, the incidence of tick-borne diseases,
ncluding rickettsiosis, may be very high. A vast Asiatic ter-
itory with different biotopes harbors lots of natural foci
f multiple tick species. For the moment, 9 rickettsial dis-
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ases are more or less regularly reported in Asia and 2
ore rickettsial species potentially associated with human
llnesses were found. Rickettsiae recognized as human
athogens are R.conorii indica, agent of Indian tick typhus
India), R.sibirica sibirica, agent of Siberian tick typhus
Eastern Russia, Mongolia, China), R. heilongjiangensis,
gent of Far Eastern tick-borne rickettsiosis (Eastren Rus-
ia, Nothern China), R. japonica, agent of Japanese spotted
ever (Japan, Korea), R.sibirica mongolitimonae (Nothern
hina), agent of LAR (Lymphangitis-associated rickettsio-
is), R.aeschlimannii, unnamed spotted fever (Kazakhstan),
. raoultii, unnamed rickettsiosis (Eastern Russia), R.honei,
hai tick typhus (Malaysia, Thailand, Laos) and Candidatus
ickettsia kellyi, unnamed rickettsiosis (India). Suggested
athogenicity were reported for R. helvetica found in Japan
nd R.tamurae (Japan, Laos). Studies show that in some
egions, the seropositivity rate for SFG is as high as 57%
or certain population groups. The real role of tick-borne
ickettsiosis in human pathology also may be shaded by lack
f diagnostic facilities and methods in some countries, mis-
iagnosing with scrub typhus, murine typhus, dengue fever
nd other clinically resembling entities.
oi:10.1016/j.ijid.2008.05.155
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crub typhus is recently recognized as a common cause of
cute fever in rural Asia. Clinical presentations of scrub
yphus vary widely from acute ﬂu-like syndrome, with or
ithout signs of organ dysfunction such as jaundice or renal
nsufﬁciency, to multi-organ dysfunction mimicking sepsis
yndrome. Acute undifferentiated fever (AUF) with or with-
ut organ dysfunction is the major clinical presentation of
crub typhus. The incidence of scrub typhus ranged from 1.1
o 19.3% in various studies conducted in indigenous patients
ho presented with AUF in rural hospitals in Malaysia,
ndonesia and Thailand. The incidence of scrub typhus,
urine typhus, and SFG rickettsioses was 7.8%, 2.4%, and
% respectively in a recent study conducted in patients with
UF who presented with severe manifestations in Thailand.
aundice, renal dysfunction, abnormal chest radiography on
dmission occurred in 21%, 35.7%, and 50% respectively in
atients with severe scrub typhus. Multiorgan dysfunction or
epsis occurred in 14%. Clinical spectrum of severe murine
yphus and SFG rickettsioses were similar to scrub typhus.
he reported mortality of severe scrub typhus varied from
.4%to 16.7%.
Awareness that scrub typhus is one of the common cause
f AUF in adults in rural Asia improves the probability of an
ccurate clinical diagnosis. Early recognition and appropri-
te treatment reduce morbidity and mortality. Results from
ecent clinical studies from Thailand indicate that rational
ntimicrobial therapy would be doxycycline in mild cases
nd a combination of either cefotaxime or ceftriaxone and
oxycycline in severe cases. Azithromycin could be consid-
red as an alternative treatment when ever doxycycline
